DAIC Top 20 for 2022

As 2022 comes to a close, the Diagnostic and Interventional Cardiology team takes a look at the year's most viewed content. Here is a rundown of what viewers found most intriguing in 2022:

1. What We Know About Cardiac Long-COVID Two Years Into the Pandemic

2. Pig Heart Transplant Patient Continues to Thrive

January 2, 2023 — The U.S. Food and Drug Administration (FDA) has approved the BioFreedom Drug Coated Coronary Stent (DCS) System – P190020 from Biosensors International. The BioFreedom Drug Coated Coronary Stent System is intended to treat a narrowed blood vessel (coronary artery) caused by coronary artery disease.

January 2, 2023 — The U.S. Food and Drug Administration (FDA) has given the approval to market to The Edwards Lifesciences PASCAL Precision Transcatheter Valve Repair System. The PASCAL Precision Transcatheter Valve Repair System is used to repair the mitral valve of the heart without the need for open-heart surgery.  The device system includes a permanent implant and a delivery system.

The DAIC team wishes you a very happy and safe New Year! 

December 30, 2022 — The Cardiovascular Research Foundation (CRF) recently announced that Alexandra Popma, MD, has joined the organization as Executive Director of the CRF Clinical Trials Center (CTC).

December 30, 2022 — Azmi Atiya, MD, an established and highly respected cardiothoracic surgeon in the San Fernando Valley, has joined the 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now